On Monday, Shares of Delta Air Lines, Inc. (NYSE:DAL), lost -5.01% to $40.75.
Delta Air Lines, is hoping to strengthen partnerships with carriers in South Korea, Mexico and Brazil, and it has been approached about investing in Japan’s bankrupt Skymark Airlines, Delta’s president Ed Bastian told reporters Monday, according to Reuters.
The comments, made on the sidelines of the International Air Transport Association’s (IATA) annual meeting, reflect Delta’s focus on streamlining flight service through cross-country partnerships and ventures. Reuters Reports.
Bastian declined to comment on the status of the Skymark investment talks and what their outcome might be. Aircraft leasing firm Intrepid Aviation Ltd, the biggest creditor of Skymark Airlines, is seeking another sponsor for the failed budget carrier instead of ANA Holdings Inc, a Japanese rival airline bidding to take part in the restructuring.
Delta is also interested in growing its relationship with long-time partner Korean Air Lines Co Ltd after their ties were weakened by Delta’s acquisition of Northwest Airlines, which already had extensive Asian routes and competed with KAL, Bastian said. Reuters added.
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita.
Shares of AbbVie Inc. (NYSE:ABBV), inclined 0.58% to $67.79, during its last trading session.
AbbVie, launched its second annual Week of Possibilities volunteer program, with 3,100 employees globally volunteering more than 14,000 service hours to transform schools and communities where AbbVie employees live and work.
For 2015, the program comprises more than 39 countries and more than 55 separate hands-on service projects, with a special emphasis on transforming education in ways that will improve the lives of those in underserved populations.
AbbVie launched Week of Possibilities in 2014 as a local initiative in which employees volunteered more than 6,800 hours to renovate schools and other learning facilities and provide educational materials to students in North Chicago, Ill., and Worcester, Mass. This year, the program has been expanded to comprise projects in Australia, Brazil, China, Italy, Japan, Turkey, Russia and 31 other countries.
For 2015, AbbVie and the AbbVie Foundation have committed more than $1.3 million to Week of Possibility projects, and the company has donated the time of all its employee volunteers to assist carry out the projects.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, counting those with compensated cirrhosis.
Finally, Marvell Technology Group Ltd. (NASDAQ:MRVL), ended its last trade with -2.18% surge, and closed at $13.89.
Marvell Technology Group, declared the launch of Marvell’s ARMADA® Mobile PXA1936 octa-core 64-bit 5-mode 4G LTE turnkey reference design to accelerate the mass adoption of mobile solutions. Building on the recently declared ARMADA Mobile PXA1936 system-on-chip (SoC), the PXA1936 turnkey reference platform provides complete design collateral counting hardware design, full software release, and manufacturing tools dramatically reducing OEM’s time-to-market in addition to optimizing the bill of materials (BOM) cost of smartphones and tablets. The platform also comprises Marvell’s RF transceiver RF858, power administration IC, PM880, with integrated audio codec and battery charger, Marvell’s award-winning Avastar® 88W8777, and location solution, L200R.
The PXA1936 octa-core turnkey reference design is a major effort by Marvell to provide end-to-end solutions, building on Marvell’s advanced SoC designs, which are optimized for performance and cost. With Marvell’s turnkey reference platform, an OEM can drastically reduce the time to mass production with the approved and required carrier and field testing.
Key features of Marvell’s ARMADA Mobile PXA1936 Turnkey Reference Design comprise support for:
- 5″ HD (1280×720) screen resolution
- 4G LTE with DSDS
- Octa-core A53 1.5GHz
- 13MP rear camera/5MP front camera
- 16GB Flash and 2GB RAM
- Android 5.1 Lollipop
- 2500mAh battery
Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
